Clinical Trial Update: Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without Comorbidity [NA]

View source ↗

Summary

The clinical trial evaluating an endoluminal-suturing device for endoscopic gastric reduction in class I/II obesity has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Bariatric Surgery, Morbid Obesity | NA | Status: TERMINATED